PKD2 and autosomal dominant polycystic kidney disease: Taking our findings together with those of other distinguished reports, we deduced the molecular mechanism of rapamycin effect on ADPKD as follows: PC2 dysfunction causes PC1 C‐terminal region (Cterm) to mislocalize and significantly down‐regulate PC1 expression (Fig. S7) 69, 70, 71.